CVS Company Profile and Key Details

Q: Who are the executives of CVS?

Mr. Samrat S. Khichi Esq.Executive Vice President of Corporation Devel., Public Policy & Regulatory Affairs and Gen. CounselMr. Thomas Michael MoriartyExecutive Vice President & Gen. CounselMr. J. David Joyner CEBSExecutive Vice President & Pres of Pharmacy ServicesMr. David A. FalkowskiExecutive Vice President & Chief Compliance OfficerMr. Prem S. Shah Pharm.DExecutive Vice President, Chief Pharmacy Officer of CVS Health and Co-Pres of Pharmacy & Consumer WellnessMr. Prem S. Shah Pharm.D, Pharm.D.EVice President, Chief Pharmacy Officer & Co-Pres of Pharmacy and Consumer WellnessMr. Larry McGrathSenior Vice President of Bus. Devel. & Investor RelationsMr. James David ClarkSenior Vice President, Controller & Chief Accounting OfficerMs. Karen Sue LynchPres, Chief Executive Officer & DirectorMr. Laurence F. McGrathSenior Vice President of Bus. Devel. & Investor RelationsDr. Alan M. Lotvin M.D.Executive OfficerMs. Laurie P. HavanecExecutive Vice President & Chief People OfficerMr. Tilak MandadiExecutive Vice President and Chief Digital, Data, Analytics & Technology OfficerMr. Shawn Michael GuertinExecutive Vice President & Chief Financial Officer

NYSE : CVS

CVS Health

$73.49

1+1.38%

At Close 4:00 PM

64.14

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

CVS Health Corporation (CVS) stock surged +1.38%, trading at $73.49 on NYSE, up from the previous close of $72.49. The stock opened at $72.46, fluctuating between $72.12 and $73.68 in the recent session.

Stock Snapshot

72.49

Prev. Close

93.49B

Market Cap

72.12

Day Low

52.87

P/E Ratio

1.39

EPS (TTM)

8.07

Cash Flow per Share

72.46

Open

1.27B

Number of Shares

73.68

Day High

99.79%

Free Float in %

59.36

Book Value

6.03M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	72.50	73.68	72.12	73.49	6.03M
Apr 01, 2026	72.06	72.75	71.82	72.49	4.95M
Mar 31, 2026	70.40	72.20	70.25	71.82	7.72M
Mar 30, 2026	71.13	71.46	69.51	70.14	7.19M
Mar 27, 2026	71.10	71.43	69.67	70.08	6.1M
Mar 25, 2026	72.74	73.38	71.44	72.18	5.36M
Mar 24, 2026	71.00	73.28	70.25	72.80	8.4M
Mar 23, 2026	72.29	72.46	70.61	71.29	8.14M
Mar 20, 2026	71.50	71.73	70.21	71.48	18.62M
Mar 19, 2026	73.20	73.85	71.60	71.86	8.95M
Mar 18, 2026	74.39	74.47	73.00	73.02	6.98M
Mar 17, 2026	76.33	76.62	74.12	74.81	8.34M
Mar 16, 2026	76.45	77.08	75.77	75.84	5.38M
Mar 13, 2026	76.84	77.17	76.03	76.13	4.54M
Mar 12, 2026	76.81	77.58	75.99	76.07	7.72M
Mar 11, 2026	76.00	76.51	75.32	75.72	5.53M
Mar 10, 2026	78.59	78.75	76.10	76.32	6.46M
Mar 09, 2026	77.24	78.41	76.30	78.26	6.87M
Mar 06, 2026	78.77	78.86	76.93	77.92	7.14M
Mar 03, 2026	81.18	81.69	79.13	80.49	7.09M

Contact Details

Woonsocket, RI 02895

United States

https://www.cvshealth.com 401 765 1500

About Company

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Stock Peers

ELV

2.24+0.75%

Elevance Health Inc.$300.74 UNH

3.28+1.20%

UnitedHealth Group Incorporated$277.26 CI

2.7+1.01%

Cigna Corporation$270.02 HUM

0.9+0.51%

Humana Inc.$177.85 MOH

3.56+2.62%

Molina Healthcare, Inc.$139.38 CNC

1.15+3.39%

Centene Corporation$35.10 BHG

1.4+9.36%

Bright Health Group, Inc.$16.35 OSCR

0.19+1.62%

Oscar Health, Inc.$11.92

Company Overview

CVS Health Corporation (NYSE:CVS) closed at $73.49 USD, gaining $1.00 (1.38%) from the previous close of $72.49. The stock is currently mid-range between its 52-week high and low $58.35 and $85.15. With a market capitalization of about $93.49 billion, CVS Health Corporation is classified as a large-cap and shows lower-than-market volatility (beta ~0.51). Key stats such as the average daily volume over the past year has been around 8.81 million shares, volume is running light vs its 52-week average. Headquartered in Woonsocket, RI, CVS Health Corporation operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO J. David Joyner, the company employs approximately 300,000 people and listed since November 20, 1996. CVS Health Corporation provides health services in the United States.

Technical Performance

CVS has shown mixed momentum, losing -0.34% over the past week and -2.94% over the past quarter, though year-to-date performance is up 0.92%. Short-term trend indicators are mixed aligned (SMA20 1.88%, SMA50 -0.41%, SMA200 6.93%). The stock’s 14-day RSI is 52.0 (neutral), while the ATR of 2.45 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -8.39% below its high and over 33.69% above its low. Average 10-day trading volume of 6.40 million shares is below the 3-month average of 8.84 million, indicating normal recent market interest.

Valuation Metrics

CVS Health Corporation trades at a P/E ratio of 52.79, slightly above the S&P 500 average, with a price-to-sales ratio of 0.23 and a price-to-book ratio of 1.24 suggesting the stock is closer to book value. The P/FCF stands at 11.98, also below market averages.

Dividend & Fair Value

CVS Health Corporation last paid a dividend of 2.66 per share, this equals a trailing yield of roughly 4.26%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $691.41. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

CVS Health Corporation generated EPS of $1.38 over the past year. Five-year average earnings growth is -23.94%. Wall Street analysts project EPS growth of 11.83% annually over the next five years. The latest quarter delivered EPS of $1.60. The next quarter is forecast at $2.23. Next year's EPS is expected at -$0.80. Analyst sentiment is bullish. Analyst rating data shows there are 21 Strong Buy ratings, 10 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $103.00 to $67.00. The high target offers 40.16% upside. The low target suggests -8.83% downside. The mean target is $89.64. This offers 21.98% upside. CVS Health Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 29, 2025, missed forecasts by 16.79%. The prior quarter beat by 23.97%. Over the last six quarters, Apple has recorded several small beats. These include 5.78% in August 07, 2024.

Shareholding & Insider Activity

CVS Health Corporation has 1.27 billion shares outstanding. The public float is 1.27 billion shares, elevated short interest at 1.50% of float. This equals 18.80 million shares. The short ratio is 2.41 days. Institutional investors hold 89.07% of the float. Insiders own 1.07%. ROBBINS LARRY holds 8.20 million shares, Moriarty Thomas M has 608.13 thousand shares and MERLO LARRY J has 524.03 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, CVS Health generated $357.78B in revenue, or $277.35 per share. Gross margin was 15.21%, operating margin 3.84%, and net profit margin 2.33%. Returns are modest, with ROA at 3.34% and ROE at 10.91%.
On valuation metrics, CVS Health trades at a P/E of 52.79, P/S of 0.23 and P/B of 1.24. Liquidity is tight, with a current ratio of 0.84 and quick ratio of 0.63. Operationally, the company’s inventory turnover is 18.01 and cash conversion cycle is -6.14 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 1.24, supported by a cash flow-to-debt ratio of 0.11.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, CVS Health posted revenue of $357.78B, down slightly from $322.47B in the prior quarter. Gross profit was $54.43B (margin 15.21%). Operating income was $13.74B (margin 3.8%). Net income was$8.34B (EPS $6.49).
The company ended the quarter with $11.46B in cash and short-term investments, a total debt of $79.39B, and net debt of $71.19B. Total assets were $249.73B, with equity of $76.64B. Financials further reflected stability, with operating cash flow of $13.43B, free cash flow of $10.40B, and capital expenditures of - $3.03B.

Price Forecast & Outlook

Our AI price prediction model suggests that CVS Health Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.56%, with price expected at $68.67 by April 16, 2026, within a range of $66.75 to $70.43 3-Month Outlook: Projected fall of -18.15%, reaching $60.15 by July 01, 2026, with a range of $54.83 to $65.48. 1-Year Outlook: Projected gain of 3.91%, with price at $76.36 by April 02, 2027, within a range of $73.21 to $79.98.

Key Takeaways

CVS Health Corporation (NYSE:CVS) shares are flat 0.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows CVS Health Corporation trading at a premium to the broader market with a P/E of 52.79. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $86.33, suggesting 17.47% upside. Our AI forecast model points to short-term weakness (-6.56% over two weeks), a medium-term fall (-18.15% over three months), and a longer-term gain (3.91% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current CVS Health Corporation (CVS) stock price?

CVS Health Corporation (NYSE: CVS) stock price is $73.49 in the last trading session. During the trading session, CVS stock reached the peak price of $73.68 while $72.12 was the lowest point it dropped to. The percentage change in CVS stock occurred in the recent session was 1.38% while the dollar amount for the price change in CVS stock was $1.00.

CVS's industry and sector of operation?

The NYSE listed CVS is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector. CVS Health Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CVS?

Mr. Samrat S. Khichi Esq.
Executive Vice President of Corporation Devel., Public Policy & Regulatory Affairs and Gen. Counsel
Mr. Thomas Michael Moriarty
Executive Vice President & Gen. Counsel
Mr. J. David Joyner CEBS
Executive Vice President & Pres of Pharmacy Services
Mr. David A. Falkowski
Executive Vice President & Chief Compliance Officer
Mr. Prem S. Shah Pharm.D
Executive Vice President, Chief Pharmacy Officer of CVS Health and Co-Pres of Pharmacy & Consumer Wellness
Mr. Prem S. Shah Pharm.D, Pharm.D.
EVice President, Chief Pharmacy Officer & Co-Pres of Pharmacy and Consumer Wellness
Mr. Larry McGrath
Senior Vice President of Bus. Devel. & Investor Relations
Mr. James David Clark
Senior Vice President, Controller & Chief Accounting Officer
Ms. Karen Sue Lynch
Pres, Chief Executive Officer & Director
Mr. Laurence F. McGrath
Senior Vice President of Bus. Devel. & Investor Relations
Dr. Alan M. Lotvin M.D.
Executive Officer
Ms. Laurie P. Havanec
Executive Vice President & Chief People Officer
Mr. Tilak Mandadi
Executive Vice President and Chief Digital, Data, Analytics & Technology Officer
Mr. Shawn Michael Guertin
Executive Vice President & Chief Financial Officer

How CVS did perform over past 52-week?

CVS's closing price is 25.95% higher than its 52-week low of $58.35 where as its distance from 52-week high of $85.15 is -13.69%.

How many employees does CVS have?

Number of CVS employees currently stands at 300,000.

Link for CVS official website?

Official Website of CVS is: https://www.cvshealth.com

How do I contact CVS?

CVS could be contacted at phone 401 765 1500 and can also be accessed through its website. CVS operates from One CVS Drive, Woonsocket, RI 02895, United States.

How many shares of CVS are traded daily?

CVS stock volume for the day was 6.03M shares. The average number of CVS shares traded daily for last 3 months was 8.81M.

What is the market cap of CVS currently?

The market value of CVS currently stands at $93.49B with its latest stock price at $73.49 and 1.27B of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	300000
Beta	0.51
Sales or Revenue	$357.78B
5Y Sales Change%	0.494%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Plans

CVS Company Profile and Key Details

CVS Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Valuation Metrics

Shareholding & Insider Activity

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways